Clinical Trial

The Effect of the HEP Approach in Infants With Down Syndrome

Study acronym: HEP-DS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 14, 2025 (before its estimated December 3, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study evaluates the effect of the HEP (Homeostasis-Enrichment-Plasticity) approach on motor and sensory development in infants with Down syndrome. Thirty-two infants will receive either HEP or traditional therapy over 12 sessions, and outcomes will be measured using standardized developmental tests.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-01.
Status change: Not Yet Recruiting → Recruiting 2025-11-13
Trial Details
NCT Number NCT07163780
Lead Sponsor Izgi Miray Demirbag
Conditions Down Syndrome (DS)
Enrollment 26 participants
Start Date 2025-09-03
Primary Completion 2025-12-03 (estimated)
Study Completion 2025-12-03 (estimated)
Updated on ClinicalTrials.gov 2025-11-14